Related Experiment Videos
Clinical implications of matrix metalloproteinases
Malay Mandal1, Amritlal Mandal, Sudip Das
1Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, India.
Molecular and Cellular Biochemistry
|October 28, 2003
Summary
Matrix metalloproteinases (MMPs) are key enzymes in health and disease. Inhibiting MMPs shows promise for treating neurological diseases and cancer by blocking their harmful effects.
Area of Science:
- Biochemistry
- Neuroscience
- Pathology
Background:
- Matrix metalloproteinases (MMPs) are neutral proteinases vital for development and wound healing.
- MMPs play significant roles in pathological processes like cancer metastasis, joint destruction, atherosclerosis, fibrosis, emphysema, and neuroinflammation.
- In the central nervous system (CNS), MMPs degrade basal lamina, disrupt the blood-brain barrier, and contribute to neuroinflammation.
Purpose of the Study:
- To explore the role of MMPs in various diseases, particularly in the CNS.
- To review the therapeutic potential of MMP inhibitors.
- To discuss future directions in designing selective MMP inhibitors with minimal side effects.
Main Methods:
- Review of existing literature on MMP function and inhibition.
- Analysis of MMP involvement in pathological processes.
- Examination of current clinical trials for MMP inhibitors.
Main Results:
- MMP inhibition has demonstrated efficacy in preventing disease progression in preclinical models.
- Several MMP inhibitors are currently undergoing clinical trials for MMP-mediated diseases.
- Catechins and Novastal are examples of MMP inhibitors in clinical trials.
Conclusions:
- Targeting MMPs offers a promising therapeutic strategy for a range of diseases, including neurological disorders and cancer.
- Future research should focus on developing selective MMP inhibitors that target multiple binding sites for enhanced efficacy and reduced side effects.